COA 2608190025 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Pept2608190025Label 10 mg · Lab measured 10.56 mg
106% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.6 mg using the measured mass, against 2.5 mg on the label — 6% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2608190025 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 27 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of SS-31 (Elamipretide) from Peptide Plugs, performed by freedomdiagnosticstesting.com on August 22, 2026. Reported purity: 99.87%. Net content: 10.56 mg against 10 mg labeled (106% of label). Endotoxins: Pass (<0.05 EU/mL). Heavy metals: ICP-MS: Arsenic, Cadmium, Lead, and Mercury below reporting/specification limits; No Fentanyl Detected. Batch 7208100C-DK. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| 160-450X-DK | 16 Jul 2026 | freedomdiagnosticstesting.com | 99.89% | 97% | ✓ Lab-verified |
| 160-450L-DK | 16 Jul 2026 | freedomdiagnosticstesting.com | 99.93% | 103% | ✓ Lab-verified |
| 144-01-DK | 22 Jun 2026 | freedomdiagnosticstesting.com | 99.95% | 107% | ✓ Lab-verified |
| 122-02-DK | 20 May 2026 | freedomdiagnosticstesting.com | 99.89% | 99% | ✓ Lab-verified |
| 121-A-D | 22 Apr 2026 | freedomdiagnosticstesting.com | 99.86% | 102% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion